PHLDA2 Drives Malignant Progression in Lung Adenocarcinoma via ELK1-Mediated Transcriptional Activation

Fei Ming, DaiPing Zhang

PDF(15970 KB)
For Authors|For Editors|For Reviewers
PDF(15970 KB)
Discovery Medicine ›› 2025, Vol. 37 ›› Issue (202) : 2579-2588. DOI: 10.24976/Discov.Med.202537202.216
Article

PHLDA2 Drives Malignant Progression in Lung Adenocarcinoma via ELK1-Mediated Transcriptional Activation

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

Highlight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2025, 37(202): 2579-2588 https://doi.org/10.24976/Discov.Med.202537202.216

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(15970 KB)

Accesses

Citation

Detail
Sections
Recommended
Follow Us on
Copyright © 2025.
By using this website, you agree to our Terms & Conditions and Privacy Policy.  
  • Disclaimer
    The statements, opinions and data contained in Discovery Medicine are solely those of the individual authors and contributors and not of the journal and the editor(s). Discovery Medicine stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

    • /

    〈 〉